Entasis Therapeutics Holdings Inc (ETTX)

US2936141033 - Common Stock

2.19  -0.01 (-0.45%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2022-3-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
0.000.000.007.00M5.00M
Operating Expenses
55.57M52.32M54.23M53.94M43.21M
Research and Development
38.73M37.10M41.02M40.17M33.05M
Selling, General, and Administrative Expenses
16.84M15.21M13.21M13.77M10.16M
Operating Income
-55.57M-52.32M-54.23M-46.94M-38.21M
Interest Income/Expense
-1.00K10.00K170.00K1.46M390.00K
Other Income/Expense
3.86M5.16M3.56M2.30M5.34M
Income Before Taxes
-51.70M-47.14M-50.50M-43.17M-32.48M
Income Tax
N/AN/A0.00680.00K470.00K
Net Income
-51.70M-47.14M-50.50M-43.85M-32.95M
EBITDA
-55.48M-52.22M-54.09M-46.80M-38.05M
 
Per Share Data
EPS Diluted Total Ops
-1.13-1.09-2.10-3.33-2.52
Non GAAP EPS
-1.12-1.09-2.43-3.34N/A
 
Statistics
Profit Margin
N/AN/AN/A-626.43%-659.00%
Operating Profit Margin
N/AN/AN/A-670.57%-764.20%

All data in USD

Charts